Recommendations for treatment of hypothyroidism with levothyroxine and levotriiodothyronine: a 2016 position statement of the Italian Society of Endocrinology and the Italian Thyroid Association
- 967 Downloads
Levothyroxine (L-T4) is recommended as lifelong replacement therapy for hypothyroidism. Recent clinical and experimental data support the addition of levotriiodothyronine (L-T3) treatment in some selected hypothyroid patients when their symptoms persist and their quality of life remains impaired despite adequate L-T4 monotherapy. An increase in L-T3 prescriptions has been recently observed in Italy due to availability of different L-T3 formulations, making it possible to clinicians to prescribe L-T3 alone or in combination with L-T4. The aim of the present position statement was to define the correct clinical indications, schedule, duration of treatment and contraindications of combined treatment with L-T4 and L-T3 in hypothyroid patients in an attempt to guide clinicians and to avoid potential adverse effects of overtreatment.
KeywordsHypothyroidism Replacement therapy TSH-suppressive therapy l-Thyroxine l-Triiodothyronine Deiodinases Clinical symptoms Quality of life Cognition Mood Depression Body weight Heart rate and patient preference for combined therapy Thyroidectomized patients Polymorphism in type 2 deiodinase gene
The authors thank Prof. Leonidas Duntas, University of Athens, and Prof. Francesco Celi for their valuable suggestions in the preparation of the manuscript.
Compliance with ethical standards
Conflict of interest
The panel members worked on this statement without any financial or commercial support.
This article does not contain any study with human participants or animals performed by any of the authors.
No informed consent.
- 8.Garber JR, Cobin RH, Gharib H et al (2012) American Association of Clinical Endocrinologists and American Thyroid Association taskforce on hypothyroidism in adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid 22:1200–1235CrossRefPubMedGoogle Scholar
- 9.Jonklaas J, Bianco AC, Bauer AJ et al (2014) American Thyroid Association task force on thyroid hormone replacement. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid 24:1670–1751CrossRefPubMedPubMedCentralGoogle Scholar
- 14.Biondi B, Celi F, Duntas L et al (2015) Terapia sostitutiva combinata con L-T4 e L-T3 nell’ipotiroidismo. L’Endocrinologo 16:264–268Google Scholar
- 19.Hennessey JV, Malabanan AO, Haugen BR, Levy EG (2010) Adverse event reporting in patients treated with levothyroxine: results of the Pharmacovigilance Task Force survey of the American Thyroid Association, American Association of Clinical Endocrinologists, and The Endocrine Society. Endocr Pract 16:357–370CrossRefPubMedGoogle Scholar
- 22.Yavuz S, Linderman JD, Smith S, Zhao X, Pucino F, Celi FS (2013) The dynamic pituitary response to escalating-dose TRH stimulation test in hypothyroid patients treated with liothyronine or levothyroxine replacement therapy. J Clin Endocrinol Metab 98:E862–E866CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Jonklaas J, Burman KD. 2016 Daily Administration of Short-Acting Liothyronine Is Associated with Significant Triiodothyronine Excursions and Fails to Alter Thyroid-Responsive Parameters. Thyroid Google Scholar
- 27.Leese GP, Soto-Pedre E, Donnelly LA (2016) Liothyronine use in a 17 year observational population-based study—the tears study. Clin Endocrinol. doi: 10.1111/cen.13052
- 40.WalshJ P, Shiels L, Lim EM et al (2003) Combined thyroxine/liothyronine treatment does not improve well-being, quality of life or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab 88:4543–4550CrossRefGoogle Scholar
- 45.Appelhof BC, Fliers E, Wekking EM et al (2005) Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. J Clin Endocrinol Metab 90:2666–2674CrossRefPubMedGoogle Scholar
- 50.Carr D, McLeod DT, Parry G, Thornes HM (1988) Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment. Clin Endocrinol 28:325–333CrossRefGoogle Scholar
- 53.Carr D, McLeod DT, Parry G, Thornes HM (1988) Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment. Clin Endocrinol 28:325–333CrossRefGoogle Scholar
- 55.Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1–133CrossRefPubMedGoogle Scholar